Vets Are Finally Discussing CBD With Pet Owners — Here’s Why 2026 Is Different
This article contains affiliate links. If you purchase through our links, we may earn a commission at no extra cost to you.
For years, veterinarians interested in discussing cannabis-related products with pet owners faced a quiet legal obstacle: professional liability and state licensing boards warned that recommending or even discussing cannabis products for animals could jeopardize their licenses. That wall is crumbling in 2026. A growing number of states have passed or are advancing legislation that explicitly protects veterinarians who discuss hemp-derived CBD and cannabis products with clients — a shift that is reshaping the pet wellness market and opening new channels for consumer education.
The most recent example is Maryland. In March 2026, Maryland delegates unanimously passed a bill that protects veterinarians from licensing board discipline when they discuss cannabis treatment options for pets. The vote signals a meaningful shift in professional acceptance: unanimous passage in a state legislative body is a strong consensus signal that the legal environment around veterinary cannabis discussion is changing rapidly.
Why This Matters for Pet Owners
The practical implications for pet owners are immediate. When a veterinarian can openly discuss CBD or cannabis options for a pet’s care — covering what products are available, what doses have been explored in research, and what risks or interactions to consider — pet owners gain access to more complete information for decision-making.
Prior to legislative protections, many veterinarians either refused to discuss cannabis products entirely or provided vague, liability-hedged responses that left pet owners navigating the market on their own. The resulting information vacuum pushed consumers toward marketing claims and anecdotal reviews rather than professional guidance.
Maryland’s unanimous passage suggests that even in politically mixed environments, the principle of protecting veterinary-client communication around cannabis products is broadly palatable. It is consistent with the general direction of veterinary cannabis legislation nationally — with states like California, Colorado, and Oregon already having moved in this direction in prior legislative sessions.
The Pet CBD Market Behind the Legislation
The legislative momentum is not occurring in a vacuum. The pet CBD market is growing rapidly. Research firm Future Market Insights estimates the category will be valued at approximately $600 million in 2026, with a compound annual growth rate of 33% through the next decade as veterinary acceptance, product quality, and consumer awareness continue to develop in parallel.
That growth is driving real product innovation. The pet CBD category has expanded well beyond the basic hemp oil drops that characterized its early years. Today’s market includes breed-specific formulations, condition-targeted products, and increasingly sophisticated quality control standards including third-party laboratory verification and Certificate of Analysis documentation.
The National Animal Supplement Council (NASC) has been working to establish voluntary quality standards for pet hemp products, filling part of the regulatory gap created by the absence of federal oversight specifically targeting hemp-derived pet supplements.
What the Research Currently Shows
Veterinary research on CBD for pets remains in relatively early stages compared to human CBD research. A small number of peer-reviewed studies, primarily focused on dogs, have explored CBD’s effects on seizure activity, osteoarthritis-related mobility, and behavioral indicators of anxiety. The results have been generally positive in these limited studies, but the research base is not yet large enough to support broad clinical recommendations.
What is consistently supported by available research: CBD is generally well-tolerated in dogs at moderate doses when administered orally, with adverse events typically limited to sedation and gastrointestinal upset at higher doses. The research does not support making specific clinical claims, and veterinarians discussing CBD with clients should frame it within the existing evidence base.
How to Find Reliable Pet CBD Products
With veterinary discussion becoming more accessible, pet owners are in a better position to make informed decisions. Products formulated specifically for pets — with appropriate dosing guidelines, third-party lab verification, and transparent ingredient disclosure — are meaningfully different from human CBD products repurposed for animal use.
Look for products that include a Certificate of Analysis from an ISO-accredited laboratory, clear dosing guidance by weight, and formulations that avoid additives such as xylitol, which is toxic to dogs. Pet-specific brands operating within established quality frameworks are the lowest-risk starting point for consumers exploring this category.
These statements have not been evaluated by the Food and Drug Administration. CBD products for pets are not intended to diagnose, treat, cure, or prevent any disease. CBDworldnews.com reports on the CBD industry for informational and news purposes only. Nothing on this site constitutes veterinary or medical advice. Always consult a licensed veterinarian before introducing any new supplement to your pet’s routine.
Learn more:
→ CBD Products for Dogs and Cats: What Pet Owners Should Know
